Next, to assess intestinal mucosa function, it was determined Klf4 mRNA expression, observing that it was increased in the MI supplementation group compared to NAFLD mice (Figure 3d). The gene discussed is KLF4; the disease is metabolic dysfunction-associated steatotic liver disease.